The Diagnostic Industry's Home Page
360Dx is the leading source for breaking news on the diagnostic market.
Your free 360Dx account gives you instant access to our real-time reporting on breaking industry news.
Only 360Dx delivers:
• A team of expert journalists focused entirely on diagnostics and clinical labs
• In-depth analysis of regulatory, reimbursement, and policy trends
• Insider perspective on the key trends in the field
Get the full story with 360Dx Premium!
360Dx Premium provides exclusive, in-depth coverage of the latest trends in the diagnostic and clinical lab markets. Upgrade your account to get the best of 360Dx's original reporting and track the topics of most interest to you.
Premium membership gives you unrestricted access across the entire 360Dx site, as well as our sister site, GenomeWeb.com. This entitles you to any article featuring the 360Dx Premium icon:
Premium access also entitles you to opt into any of our weekly topical mailings, which include:
- Molecular Diagnostics
- Infectious Disease
Pricing is based on the number of users included in your 360Dx Premium membership.
Company-wide licenses are available for organizations of any size, from small startups to multinational organizations.
Interested? Try 360Dx Premium for 90 days for only $95. The trial offer is for new subscribers only and is non-refundable.
If you still have questions, please contact [email protected] for further information.
Terms of Service for 360Dx Premium Licenses
All 360Dx content is protected by US and International copyright laws, and may not be copied, reprinted, published, translated, hosted, or otherwise distributed by any means without explicit permission.
Password sharing and redistribution of content are violations of the 360Dx Premium license agreement and are monitored. All Premium license users must log in with their own individual work email addresses. Premium users may not store premium articles on an internal or external web page accessible to other users, nor may they email full text or partial text articles to anyone inside or outside the subscribing organization without prior permission of GenomeWeb LLC.